U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.
Related Posts
This AI Paper from Google Unveils How Bayesian Neural Fields Revolutionize Spatiotemporal Forecasting for Large Datasets
One of the central challenges in spatiotemporal prediction is efficiently handling the vast and complex datasets produced in diverse domains…
Inside the deal: Roche and Zealand Pharma’s $5.3 billion obesity drug gambit
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand…
Volkswagen posts 15% fall in annual profit amid restructuring, expects revenue to rise in 2025
The carmaking giant said it expects to see revenue growth in 2025.